Shigella sonnei vaccine (GlaxoSmithKline)

N/A

Report date: 2024/11/11 20:00:37

Base Information

Drug NameShigella sonnei vaccine (GlaxoSmithKline)
Drug Alias Name1790-GAHB vaccineGSK-3536852AGSK-3902986A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDysentery, Bacillary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomFrance
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma AgGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcGsk Vaccines Institute For Global Health Srl
Active IndicationsN/A
Inactive IndicationsDysentery, Bacillary

Other Information

ATC CodeN/A
Related LinksN/A